PubRank

A D Spigelman

Author PubWeight™ 65.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The intention to hasten death: a survey of attitudes and practices of surgeons in Australia. Med J Aust 2001 4.06
2 Adverse events in surgical patients in Australia. Int J Qual Health Care 2002 2.80
3 Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 1993 2.70
4 Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 2000 2.29
5 Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut 2002 1.81
6 Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Dis Colon Rectum 1993 1.64
7 Hereditary non-polyposis colorectal cancer and the role of hPMS2 and hEXO1 mutations. Clin Genet 2004 1.59
8 Development of duodenal cancer in a patient with familial adenomatous polyposis. J Gastroenterol 2000 1.41
9 Relationship between colorectal and prostate cancer. Dis Colon Rectum 1995 1.38
10 Surgical polypectomy of duodenal adenomas in familial adenomatous polyposis: experience of two European centres. Br J Surg 1993 1.32
11 Colorectal polyp counts and cancer risk in familial adenomatous polyposis. Gastroenterology 1996 1.29
12 Effect of sulindac on small polyps in familial adenomatous polyposis. Lancet 1995 1.25
13 Upper gastrointestinal pathology in familial adenomatous polyposis: results from a prospective study of 102 patients. J Clin Pathol 1990 1.20
14 A modifying locus for familial adenomatous polyposis may be present on chromosome 1p35-p36. J Med Genet 1996 1.13
15 Surveillance of duodenal polyps in familial adenomatous polyposis: progress report. J R Soc Med 1994 1.04
16 DNA adducts, detected by 32P-postlabelling, in DNA treated in vitro with bile from patients with familial adenomatous polyposis and from unaffected controls. Carcinogenesis 1993 1.03
17 An updated mutation spectrum in an Australian series of PJS patients provides further evidence for only one gene locus. Clin Genet 2006 0.99
18 Familial adenomatous polyposis: more evidence for disease diversity and genetic heterogeneity. Gut 2001 0.97
19 The variable effect on proliferation of a colon cancer cell line by the citrus fruit flavonoid Naringenin. Colorectal Dis 2003 0.97
20 Pouch adenomas in patients with familial adenomatous polyposis. Br J Surg 1993 0.94
21 STK11 status and intussusception risk in Peutz-Jeghers syndrome. J Med Genet 2006 0.93
22 Mutation analysis of the STK11/LKB1 gene and clinical characteristics of an Australian series of Peutz-Jeghers syndrome patients. Clin Genet 2002 0.93
23 Duodenal cancer in polyposis patients. Gastroenterology 1992 0.90
24 DNA adducts detected by 32P-postlabelling, in the intestine of rats given bile from patients with familial adenomatous polyposis and from unaffected controls. Carcinogenesis 1992 0.90
25 Iatrogenic pancreatitis in familial adenomatous polyposis. Gut 1993 0.89
26 Upper intestinal surveillance in familial adenomatous polyposis. Eur J Cancer 1995 0.89
27 Can we safely delay or avoid prophylactic colectomy in familial adenomatous polyposis? Br J Surg 1996 0.87
28 Preventive measures in Peutz-Jeghers syndrome. Fam Cancer 2001 0.85
29 A programme for reducing smoking in pre-operative surgical patients: randomised controlled trial. Anaesthesia 2005 0.85
30 Overexpression of p53 in duodenal tumours in patients with familial adenomatous polyposis. Br J Surg 1996 0.85
31 Relationship between APC genotype, polyp distribution, and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis. Dis Colon Rectum 2001 0.84
32 Tissue prostaglandin levels in familial adenomatous polyposis patients treated with sulindac. Dis Colon Rectum 1996 0.83
33 Bile acids do not form adducts when incubated with DNA in vitro. Carcinogenesis 1994 0.81
34 Follow-up in familial adenomatous polyposis. Lancet 1993 0.81
35 Gastroduodenal lesions in familial adenomatous polyposis. Surg Today 2000 0.80
36 Malignant change in a duodenal adenoma in familial adenomatous polyposis: report of a case. Am J Gastroenterol 1998 0.80
37 Hereditary colorectal cancer: keeping it in the family--the bowel cancer story. Intern Med J 2002 0.80
38 Sulforaphane inhibits growth of a colon cancer cell line. Colorectal Dis 2004 0.79
39 Genes and carcinogens. Lancet 1989 0.79
40 Gallbladder dysplasia in patients with familial adenomatous polyposis. Br J Surg 1994 0.79
41 Audit of surgeon awareness of readmissions with venous thrombo-embolism. Intern Med J 2003 0.79
42 p53 and K-ras status in duodenal adenomas in familial adenomatous polyposis. Br J Surg 1997 0.79
43 Familial adenomatous polyposis and duodenal lymphoma: report of a case. Dis Colon Rectum 2003 0.78
44 Randomized, placebo-controlled trial of gastric acid-lowering therapy on duodenal polyposis and relative adduct labeling in familial adenomatous polyposis. Dis Colon Rectum 2001 0.78
45 Differences in the levels and pattern of DNA-adduct labelling in human cell lines MCL-5 and CCRF, proficient or deficient in carcinogen-metabolism, treated in vitro with bile from familial adenomatous polyposis patients and from unaffected controls. Carcinogenesis 1996 0.78
46 High pH reduces DNA damage caused by bile from patients with familial adenomatous polyposis: antacids may attenuate duodenal polyposis. Gut 1995 0.77
47 The use of 32P-postlabelling in studies of the nature and origin of DNA adducts formed by bile from patients with familial adenomatous polyposis and from normal patients. Mutat Res 1997 0.77
48 Can a familial gastrointestinal tumour syndrome be allelic with Waardenburg syndrome? Clin Genet 2011 0.77
49 Risk of extracolonic cancer in familial adenomatous polyposis. Br J Surg 1996 0.77
50 32P-postlabelling studies of target tissues and bile from patients with familial adenomatous polyposis and from unaffected controls. IARC Sci Publ 1993 0.76
51 An audit of open and laparoscopic inguinal hernia repair. J Qual Clin Pract 2001 0.75
52 Current surgical practice in screening for colorectal cancer based on family history criteria. Br J Surg 1999 0.75
53 Screening and management of familial adenomatous polyposis. Gut 1993 0.75
54 Association of congenital hypertrophy of the retinal pigment epithelium with familial adenomatous polyposis. Br J Surg 1990 0.75
55 Early discharge after surgery for breast cancer. Hotel wards are good option for patients. BMJ 1999 0.75
56 Duodenal polyposis in familial adenomatous polyposis. Scand J Gastroenterol 1999 0.75
57 Does more equal less or does less equal more? J Qual Clin Pract 2001 0.75
58 Colomastology as a subspecialty of surgical oncology. Br J Surg 1995 0.75
59 Ileo-anal pouch procedure. Aust N Z J Surg 1992 0.75
60 Magnetic resonance spectroscopy and breast cancer: comment. Aust N Z J Surg 1999 0.75
61 Assessment of a scoring system for breast imaging. Br J Surg 1998 0.75
62 Tumour site, sex, and survival in colorectal cancer. Lancet 2000 0.75
63 Pathogenesis and clinical management of hereditary non-polyposis colorectal cancer (Br J Surg 2002; 89: 1357-1369). Br J Surg 2003 0.75
64 Bile and the growth of intestinal polyps. Arch Surg 1992 0.75
65 Management of familial adenomatous polyposis. Baillieres Clin Gastroenterol 1992 0.75
66 Appearance of artefacts when using 32P-postlabelling to investigate DNA adduct formation by bile acids in vitro: lack of evidence for covalent binding. Carcinogenesis 1995 0.75
67 Case report: metachronous central nervous system desmoid tumours and thyroid carcinoma in a young familial adenomatous polyposis patient. Fam Cancer 2013 0.75
68 Gall-bladder agenesis and associated anomalies. HPB Surg 1995 0.75
69 Apparent nonlinear kinetics of secondary-amine tricyclic antidepressants. Clin Pharm 1984 0.75
70 Volume of infusion controller and delayed vasopressor effect. Ann Intern Med 1983 0.75
71 The functional result of pelvic ileal reservoir in 10 patients with familial adenomatous polyposis. Ann R Coll Surg Engl 1989 0.75
72 A missed breast cancer. Aust N Z J Surg 1996 0.75
73 Surveillance of ampullary adenomas in familial adenomatous polyposis. Lancet 1994 0.75
74 Large bowel cancer: guidelines and beyond. Med J Aust 1999 0.75
75 A survey of surgical audit in Australia: whither clinical governance? J Qual Clin Pract 2000 0.75